Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, LDL | 4 | 2021 | 30 | 1.150 |
Why?
|
| Endothelial Cells | 5 | 2021 | 296 | 1.040 |
Why?
|
| Scavenger Receptors, Class B | 2 | 2021 | 7 | 0.960 |
Why?
|
| Macrophages | 4 | 2016 | 431 | 0.940 |
Why?
|
| ATP-Binding Cassette Transporters | 5 | 2015 | 82 | 0.840 |
Why?
|
| Cholesterol | 7 | 2015 | 194 | 0.800 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 63 | 0.800 |
Why?
|
| Apolipoproteins E | 3 | 2018 | 129 | 0.790 |
Why?
|
| Arteries | 1 | 2021 | 67 | 0.780 |
Why?
|
| Lipoproteins | 3 | 2015 | 61 | 0.760 |
Why?
|
| Down-Regulation | 1 | 2021 | 420 | 0.700 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 325 | 0.700 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2015 | 13 | 0.650 |
Why?
|
| Serine Endopeptidases | 2 | 2015 | 36 | 0.640 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2015 | 68 | 0.620 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2016 | 245 | 0.560 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 338 | 0.540 |
Why?
|
| Sp1 Transcription Factor | 4 | 2012 | 44 | 0.510 |
Why?
|
| Apolipoprotein E4 | 1 | 2012 | 47 | 0.430 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 968 | 0.370 |
Why?
|
| Mice | 10 | 2018 | 5668 | 0.280 |
Why?
|
| Signal Transduction | 5 | 2015 | 1802 | 0.260 |
Why?
|
| Cell Line | 4 | 2016 | 1289 | 0.250 |
Why?
|
| LDL-Receptor Related Proteins | 2 | 2015 | 9 | 0.240 |
Why?
|
| Cholecystokinin | 2 | 2014 | 15 | 0.240 |
Why?
|
| Animals | 12 | 2018 | 14307 | 0.210 |
Why?
|
| Porphyromonas gingivalis | 1 | 2020 | 23 | 0.200 |
Why?
|
| Apolipoproteins B | 2 | 2018 | 18 | 0.190 |
Why?
|
| Endothelium, Vascular | 2 | 2020 | 229 | 0.190 |
Why?
|
| Up-Regulation | 2 | 2014 | 490 | 0.190 |
Why?
|
| Mice, Knockout | 5 | 2014 | 897 | 0.180 |
Why?
|
| Lipoproteins, HDL | 2 | 2018 | 43 | 0.170 |
Why?
|
| Benzo(a)pyrene | 2 | 2016 | 122 | 0.170 |
Why?
|
| Nitric Oxide | 1 | 2020 | 287 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 161 | 0.160 |
Why?
|
| Phosphorylation | 4 | 2015 | 878 | 0.160 |
Why?
|
| Aorta | 2 | 2016 | 161 | 0.160 |
Why?
|
| Microsomes, Liver | 1 | 2016 | 69 | 0.140 |
Why?
|
| Calpain | 1 | 2016 | 31 | 0.140 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 115 | 0.140 |
Why?
|
| Catalase | 1 | 2016 | 106 | 0.140 |
Why?
|
| Apolipoprotein E3 | 2 | 2012 | 10 | 0.140 |
Why?
|
| Culture Media, Conditioned | 1 | 2015 | 44 | 0.140 |
Why?
|
| Humans | 7 | 2021 | 34853 | 0.130 |
Why?
|
| Protein Kinase C | 2 | 2012 | 110 | 0.130 |
Why?
|
| Intestinal Absorption | 1 | 2014 | 19 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 181 | 0.120 |
Why?
|
| Hypercholesterolemia | 1 | 2014 | 36 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2015 | 131 | 0.120 |
Why?
|
| Binding Sites | 1 | 2015 | 597 | 0.120 |
Why?
|
| Cholagogues and Choleretics | 1 | 2012 | 3 | 0.110 |
Why?
|
| Hypertriglyceridemia | 1 | 2012 | 13 | 0.110 |
Why?
|
| Foam Cells | 1 | 2012 | 13 | 0.110 |
Why?
|
| Lipids | 1 | 2012 | 222 | 0.100 |
Why?
|
| Response Elements | 1 | 2011 | 52 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 1530 | 0.090 |
Why?
|
| Models, Biological | 1 | 2012 | 642 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 550 | 0.080 |
Why?
|
| Lipoproteins, LDL | 2 | 2018 | 61 | 0.070 |
Why?
|
| Biological Transport | 2 | 2015 | 175 | 0.060 |
Why?
|
| Plicamycin | 2 | 2011 | 9 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 73 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2012 | 834 | 0.050 |
Why?
|
| Xenobiotics | 1 | 2016 | 10 | 0.040 |
Why?
|
| Peroxides | 1 | 2016 | 20 | 0.040 |
Why?
|
| Rats, Mutant Strains | 1 | 2016 | 5 | 0.040 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2016 | 43 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2016 | 72 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2016 | 101 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 240 | 0.030 |
Why?
|
| Apolipoprotein A-I | 1 | 2015 | 21 | 0.030 |
Why?
|
| Carcinogens | 1 | 2016 | 117 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2015 | 53 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 1442 | 0.030 |
Why?
|
| Receptor, Cholecystokinin B | 1 | 2014 | 9 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 608 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2014 | 11 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2014 | 48 | 0.030 |
Why?
|
| Intestines | 1 | 2014 | 63 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 88 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 391 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 286 | 0.030 |
Why?
|
| Apolipoproteins | 1 | 2012 | 19 | 0.030 |
Why?
|
| Triglycerides | 1 | 2012 | 129 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 984 | 0.030 |
Why?
|
| Gene Expression | 1 | 2015 | 639 | 0.030 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2011 | 14 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 71 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 445 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1300 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2014 | 486 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 180 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 423 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 605 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 484 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 3261 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 913 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 1152 | 0.020 |
Why?
|
| Male | 2 | 2016 | 18870 | 0.020 |
Why?
|